Clinical trials are where the effectiveness and safety of new medication or new treatment methods for patients are explored and examined.These studies are subject to strict legal regulations. The participation in such studies is voluntary. It offers patients the opportunity to access new and potentially more effective treatments or access to therapies that are expected to be better tolerated even before they are approved.
More than 300 clinical trials are currently being carried out at the NCT. Every study is conducted according to an extensive inspection plan, also called a study protocol. The plan includes the duration of the trial, the criteria for the selection of the participants, necessary tests and procedures, which medication is administered in what dosage, as well as what the medical care following the study will look like.
Clinical trials are conducted in phases. Each phase serves to answer specific questions. Every new drug is usually tested in Phase I to III clinical trials before regulatory authorities classify it as safe and effective. Phase I and II clinical trials (known as early clinical trials) test new drugs or therapies in humans for the first time. The aim is to assess their tolerability, safety, and efficacy. We also offer Phase III trials, in which a larger group of patients is used to investigate the efficacy and safety of the drug compared to existing therapies.
All trials are conducted in accordance with the principles of good clinical practice, which are prescribed by the authorities to protect patient safety. The rights, safety, and well-being of trial participants are our top priority.